An ANOVA test was conducted to compare the mean survival time across different Ki-67 index groups (<2%, 3-20%, and ≥20%) in patients with stage IV small bowel neuroendocrine tumors. The gene discussed is MKI67; the disease is small intestine neuroendocrine neoplasm.